TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sonic Healthcare Limited ( (AU:SHL) ) has provided an update.
Sonic Healthcare Limited announced a change in the director’s interest notice, specifically concerning Christopher David Wilks. The notice details changes in the number of ordinary shares and unlisted options held directly and indirectly by the director, reflecting adjustments in the company’s stock and options management. This update is significant for stakeholders as it highlights the company’s ongoing commitment to transparency in its corporate governance practices.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$23.50 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, providing medical diagnostic services. The company focuses on delivering laboratory and radiology services to medical practitioners, hospitals, and their patients.
Average Trading Volume: 1,683,183
Technical Sentiment Signal: Sell
Current Market Cap: A$11.41B
For a thorough assessment of SHL stock, go to TipRanks’ Stock Analysis page.

